Macromolecular anti-inflammatory and barrier technology from sustainable seaweed

Technology
In market
Company

OCEANIUM presents a fucoidan-based technology from sustainably sourced seaweed, offering anti-inflammatory and barrier-enhancing properties for topical applications. Proven efficacy with a 98% redness reduction in clinical trials.

Overview

OCEANIUM has developed a groundbreaking macromolecular anti-inflammatory and barrier technology derived from sustainably sourced seaweed. The core component, fucoidan, is a sulphated polysaccharide known for its potent anti-inflammatory and calming properties. It is designed to be incorporated into various forms such as nasal sprays, creams, or ointments, depending on the intended application. Clinical trials of OCEAN ACTIVES C+ have demonstrated significant positive outcomes, including a 98% reduction in redness at a 1% dosage rate, highlighting its potential in soothing and protecting skin.

Technical specifications

Key features:

  • Utilizes a 'green' water-based extraction process, ensuring environmental sustainability
  • High molecular weight of fucoidan allows effective interaction with the epithelial barrier, forming a moisturising, microbiome-friendly layer
  • Demonstrated anti-erythema effects up to 92% in cosmetic testing
  • In vitro studies show antioxidant properties and anti-neutrophil elastase activity, promoting epithelial barrier formation
  • Designed for low systemic distribution with excellent safety profile, including safe ingestion through nasal distribution
Technology readiness level

This technology is at Technology Readiness Level 7, indicating it is at the demonstration stage in an operational environment. OCEANIUM has conducted extensive clinical trials and is seeking partners for further development and application of the technology. Future plans include human repeat insult patch testing, nasal irritancy testing, and clinical efficacy testing in both nasal spray and topical treatment formats.


About OCEANIUM

Founded in 2018 and headquartered in Oban, Scotland, OCEANIUM is a seaweed-based ingredients manufacturer that utilizes proprietary green biorefinery technology to process sustainably farmed seaweed. Their cascade biorefinery process maximizes value from the entire plant, enabling the production of a diverse suite of functional ingredients, including food additives, bioactive components for health and cosmetic applications, and innovative materials. By developing these clean-label, high-purity alternatives, the company aims to support a regenerative seaweed value chain while prioritizing both human health and ocean health.

The company serves various sectors, including food and beverage, skincare, and materials manufacturing, by offering products like their OCEAN ACTIVES range for gut health and skincare, as well as OCEAN INK, a biodegradable seaweed-derived ink. OCEANIUM partners with seaweed farmers, researchers, and commercial clients to catalyze industry growth, improve food security, and provide environmental benefits such as carbon sequestration and biodiversity support. Their work is backed by significant venture capital and research grants, and they maintain a focus on delivering measurable social, economic, and environmental impacts across the Western Hemisphere.

Sign up to access the full partnering listing.
View the details of this partnering listing and connect directly with the teams behind promising technologies.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.